N. V.  Puranik, Srivastava, P., Swami, S., Choudhari, A., and Sarkar, D., ?Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against mycobacterium tuberculosis?, RSC Advances, vol. 8, no. 19, pp. 10634-10643, 2018.

S.  Waghmode, Swami, S., Sarkar, D., Suryavanshi, M., Roachlani, S., Choudhari, P., and Satpute, S., ?Exploring the pharmacological potentials of biosurfactant derived from planococcus maritimus SAMP MCC 3013?, Current Microbiology, vol. 77, no. 3, pp. 452-459, 2020.

S.  Sarkar, Swami, S., Soni, S. Kumar, Holien, J. K., Khan, A., Korwar, A. M., Likhite, A. P., Joshi, R. A., Joshi, R. R., and Sarkar, D., ?Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols?, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.

N. V.  Puranik, Swami, S., Misar, A. V., Mamgain, R., Gulawani, S. S., Dhiman, S., and Srivastava, P., ?First synthesis of podocarflavone A and its analogs and evaluation of their antimycobacterial potential against mycobacterium tuberculosis with the support of virtual screening?, Natural Product Research, vol. 36, no. 15, pp. 3879-3886, 2022.

R.  Mamgain, Swami, S., Sarkar, D., and Srivastava, P., ?Design, synthesis, and in vitro biological evaluation of ROS-generating phenanthridin-trione-epoxide conjugates as agents against mycobacterium tuberculosis?, ChemistrySelect, vol. 8, no. 25, p. e202300416, 2023.

A.  Bavishi, Vala, H., Thakrar, S., Swami, S., Sarkar, D., Shukla, R., Kamdar, J., and Shah, A., ?Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies?, Future Medicinal Chemistry, vol. 17, no. 10, pp. 1131-1142, 2025.

A.  Bavishi, Vala, H., Radadiya, A., Swami, S., Thakrar, S., Sarkar, D., and Shah, A., ?Synthesis, biological screening, and molecular docking of hybrid pyrazole scaffolds for antitubercular and antimicrobial activity?, ChemistrySelect, vol. 10, no. 2, p. e202404830, 2025.